Vaughan Nelson Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-160
Closed -$3K 239
2023
Q2
$3K Hold
160
﹤0.01% 229
2023
Q1
$4K Sell
160
-3,375
-95% -$90.6K ﹤0.01% 212
2022
Q4
$99K Hold
3,535
﹤0.01% 202
2022
Q3
$83K Hold
3,535
﹤0.01% 191
2022
Q2
$119K Hold
3,535
﹤0.01% 197
2022
Q1
$123K Hold
3,535
﹤0.01% 194
2021
Q4
$108K Hold
3,535
﹤0.01% 191
2021
Q3
$116K Hold
3,535
﹤0.01% 198
2021
Q2
$107K Buy
+3,535
New +$116K ﹤0.01% 186

Other funds holding OGN

Vaughan Nelson Investment Management's OGN Position: Q3 2023 in Review

Vaughan Nelson Investment Management sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 160 shares — an estimated $3K sold.

Vaughan Nelson Investment Management first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $123K in Q1 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Vaughan Nelson Investment Management reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 160 Organon & Co shares in Q3 2023, an estimated $3K.
  • Vaughan Nelson Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Vaughan Nelson Investment Management's Organon & Co position peaked at $123K in Q1 2022.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Vaughan Nelson Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.